PSMB8 / Proteasome subunit beta type-8 · Western blot design guide

Design a Western Blot for PSMB8

Real validated PSMB8 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-PSMB8 WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for PSMB8: expected band ~30.4 kDa, hero antibody M02188-2, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable PSMB8 Western blot protocol sheet — expected band ~30.4 kDa, antibody M02188-2, controls and PMC citations. Open the full PSMB8 WB guide →

PSMB8 Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~30.4 kDa
Gel 12–15% (standard starting point)
Positive control ⓘ Lung (IHC candidate; verify WB) +4 more
Negative control ⓘ Adipose tissue (IHC candidate; verify WB)
Important caveats
Reasons your observed band may differ from the expected size.
PTM Phosphorylated + Cleaved
Caveat Propeptide processing
Gene-set association MSigDB Hallmark membership
Isoform 2 isoform(s)
Section 1

Real Curated PSMB8 Western Blot Protocols

The M02188-2 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysateU937 cell lysate (catalog M02188-2)
Gel %12–15% (standard starting point)
Load20–30 µg total protein per lane; optimize for abundance (standard starting point)
TransferShort semi-dry transfer; verify retention (standard starting point)
Membrane0.45 µm PVDF (standard starting point)
Blocking5% milk or 5% BSA in TBST (standard starting point)
Primary antibodyM02188-2; use the WB datasheet starting dilution (standard starting point)
Primary incubationOvernight at 4 °C (standard starting point)
Secondary antibodySpecies-matched HRP conjugate at validated dilution (standard starting point)
Secondary incubation1 h at room temperature (standard starting point)
Wash3 × 5 min in TBST (standard starting point)
DetectionECL; bracket exposures to avoid saturation (standard starting point)
Section 2

What Is the Expected PSMB8 Western Blot Band Size?

PSMB8 has a predicted 30.4 kDa precursor; propeptide cleavage and isoforms may affect migration, but no empirical band size or distinct isoform pattern is supplied.

What am I looking at on my blot?
Band near 30.4 kDaconsistent with the predicted precursor, pending identity controls
Band below 30.4 kDacould reflect removal of the residues 1–72 propeptide
Two bands at different positionscould reflect precursor and mature PSMB8
Several discrete bandscould include isoforms 1 and 2, though their migration is unknown
💡Expected PSMB8 appearanceUniProt predicts a 30.4 kDa precursor; removal of its propeptide could yield a smaller mature band, but no empirical band size is supplied, so confirm band identity with controls.
How each factor affects band size
Predicted precursor mass30.4 kDa is the UniProt prediction, not a measured band position
Propeptide at residues 1–72cleavage can produce a smaller mature protein; its apparent size is unknown
Isoform 1may differ in apparent size from isoform 2; direction and separation are unknown
Isoform 2may differ in apparent size from isoform 1; direction and separation are unknown
Why is my band missing or off?
SituationLikely causeNext action
No band in lysatePSMB8 may be below detection in the tested lysatecompare with U937 lysate as a positive control and check loading
Band higher than expectedthe 30.4 kDa precursor may be present when a mature band was expectedcompare precursor and mature forms using an appropriate band-identity control
Band lower than expectedthe residues 1–72 propeptide may have been removedcheck antibody recognition of mature PSMB8 and confirm identity
Multiple bandsprecursor processing or isoforms 1 and 2 may contributeconfirm PSMB8 specificity with depletion and compare band patterns
Weak or no signalPSMB8 may be below the assay detection limitcheck loading, antibody performance and a U937 lysate control

Sample controls for PSMB8 Western blot

🧪HPA-IHC candidate guidance (verify in WB): For positive controls for PSMB8 in Western blot, you can use lung tissue lysate.
Positive control: Lung (IHC candidate; verify WB)
Negative control: Adipose tissue (IHC candidate; verify WB)
Loading controls: Run GAPDH, β-actin, and a total-protein stain alongside the samples.
⚠️Feasibility: Tissue lysates are suitable, with adipose tissue providing a potential negative control.

HPA tissue expression evidence for PSMB8

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
Lung alveolar cells type I High Protein (IHC) HPA →
Skin lymphocytes High Protein (IHC) HPA →
Adrenal gland glandular cells Medium Protein (IHC) HPA →
Appendix glandular cells Medium Protein (IHC) HPA →
Bone marrow hematopoietic cells Medium Protein (IHC) HPA →

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
Adipose tissue adipocytes Not detected Protein (IHC) HPA →
Heart muscle cardiomyocytes Not detected Protein (IHC) HPA →
Ovary follicle cells Not detected Protein (IHC) HPA →
Skeletal muscle myocytes Not detected Protein (IHC) HPA →
Caudate neuronal cells Low Protein (IHC) HPA →
Section 3

Advanced PSMB8 Western Blot Tips

Deeper troubleshooting and optimisation questions for PSMB8, answered from its protein features.

How should PSMB8 band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
Could PSMB8 isoforms produce different bands?
Isoforms · UniProt lists isoforms 1 and 2. Isoform 2 has an alternative sequence at the N terminus, annotated as VAR_SEQ 1..49. Check whether the antibody target includes this region. Isoform annotation alone does not establish that both isoforms are expressed or resolve as separate bands.
Do annotated modifications prove a band shift?
PTM · The linked UniProt record describes protein features. A modification annotation alone does not demonstrate a visible shift; retain any condition or experimental qualifier attached to it.
Does this guide establish induction of PSMB8?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
What transfer method to use for PSMB8 Western blot?
Transfer · Plan to retain proteins around the 30.4 kDa precursor size and potentially smaller processed forms, then verify transfer with a size marker. The supplied UniProt features do not specify a membrane, transfer method, or settings.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the M02188-2 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should PSMB8 bands be quantified?
Quantitation · Define the band being measured before comparing samples. The annotated propeptide at UniProt residues 1..72 means precursor and processed PSMB8 could differ in size; the two annotated isoforms also have different N terminal sequences. Keep any separately resolved bands distinct unless their identities are verified.
Why might PSMB8 migrate below its predicted 30.4 kDa?
Interpretation · The 30.4 kDa prediction includes a propeptide at UniProt residues 1..72. Processing could produce a smaller mature protein, but these features do not establish its apparent mass or explain a particular band without experimental evidence.

PSMB8 is annotated as a zymogen with a propeptide at UniProt residues 1..72. A precursor and a processed form could differ in size. Check which form the antibody recognizes before assigning a band; the supplied features do not establish that both forms will be visible.

Compare their sizes with the 30.4 kDa precursor prediction and consider propeptide processing at UniProt residues 1..72 and the isoform 2 N terminal alternative sequence. Confirm band identity experimentally: these annotations alone do not assign an unexpected band, and no empirical apparent band is supplied.
Boster reagents

PSMB8 Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot analysis of Proteasome 20S LMP7 expression in U937 cell lysate.
Anti-PSMB8 / LMP7 Monoclonal Antibody
Cat # M02188-2

The listed anti-PSMB8/LMP7 monoclonal antibody, M02188-2, has a Western blot image showing proteasome 20S LMP7 expression in U937 cell lysate. The product lists Human, Mouse, and Rat reactivity; the supplied image documents only the stated sample context.

Which to pick: M02188-2 is the only listed option. Its Western blot image uses U937 cell lysate; check that the listed reactivity and this demonstrated sample context fit your experiment.

Source: BosterBio PSMB8 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.